北京经济技术开发区（简称"北京经开区"，也称"北京亦庄"）2025年上半年经济数据已"出炉"，多项指 标表现亮眼：地区生产总值（GDP）同比增长12.3%；工业总产值突破3400亿元，同比增长15.6%，高 于全市平均增速9.8个百分点；大中型企业研发费用同比增长25.3%，高于全市平均增速21.2个百分点； 信息服务业营业收入、批零业销售额、金融业两项净收入增速均超20%。数据显示，北京亦庄正以科技 创新为核心引擎，加速培育和壮大新质生产力，推动经济"含新量"持续攀升，高质量发展取得新突破。 新产业加速增长，工业增加值占全市比重近四成 上半年，北京亦庄作为北京先进制造业"压舱石"作用愈发凸显，实现产值3478.7亿元，同比增长 15.6%，增速大幅领先全市平均水平9.8个百分点，工业增加值占全市比重37.7％。尤为突出的是，以集 成电路、新能源汽车、新一代信息技术等为代表的新兴产业和以人形机器人、商业航天为代表的未来产 业加速增长，成为驱动区域经济高质量发展的核心引擎。 今年以来，北京亦庄新兴产业和未来产业领域捷报频传，小米汽车累计交付量已突破30万辆；京东方第 6代新型半导体显示器件生产线全面量产；优必选 ...

Core Viewpoint - The 2025 China International Fair for Trade in Services (CIFTIS) aims to enhance professionalism, marketization, and internationalization, establishing itself as a hub for policy discussions, industry solutions, and corporate innovation in the global service trade sector [1] Group 1: Event Structure and Features - The event will be held annually on the third Tuesday of September for five days, with the first three days dedicated to professional audiences and the last two days open to the public [2] - The venue has shifted from "two locations" to "one location," utilizing Shougang Park to create a "Convention and Exhibition Town," optimizing spatial layout and integrating with the overall planning of the Beijing West area [2] - The event will focus on service trade characteristics, emphasizing digitalization, greening, and standardization, with a significant portion of the exhibition area dedicated to interactive communication spaces [2] Group 2: Themes and Participation - The annual theme "Digital Intelligence Leading, Service Trade Renewed" will guide the event, showcasing new technology applications and solutions across various professional service fields, including digital technology and financial technology [2] - Australia will be the guest country, presenting the largest service trade delegation since the inception of CIFTIS, featuring major companies like ANZ Bank and unicorn enterprises [2][6] - Over 700 enterprises have expressed interest in participating, with more than 30% from outside Beijing, including over 240 Fortune 500 and industry-leading companies [5] Group 3: Forums and Discussions - The event will host 14 thematic forums and 76 specialized forums, with nearly 300 invited speakers, including government leaders and Nobel laureates, discussing topics such as e-commerce development and global green economy [4] - Specialized forums will address industry hot topics, including digital economy cooperation between Nigeria and China, and open cooperation in the telecommunications sector [4] Group 4: Brand and Resource Development - A service brand resource library will be established to enhance visibility for premier service brands, facilitating both online and offline promotional activities [3] - The event will also feature diverse activities, including cultural performances and tourism markets, to promote service consumption integration [3]

Group 1: Industry Overview - Beijing is focusing on developing a "1+4" product system in robotics, which includes humanoid robots, medical health robots, collaborative robots, special robots, and logistics robots, with over 400 core enterprises in the sector [1] - The city has the highest number of specialized "little giant" robot enterprises in the country, with 57 such companies, nearly 30 humanoid robot manufacturers, and 24 registered surgical robots, leading in these metrics nationwide [1] - The robot industry in Beijing generated over 30 billion yuan in revenue in 2024, marking a nearly 50% year-on-year growth [9] Group 2: Technological Advancements - The "TianGong Ultra" humanoid robot won the first global humanoid robot half-marathon, showcasing its long endurance and adaptability to complex terrains, leading to a surge in orders exceeding 2,500 units [2] - The "TianGong 2.0" robot, developed by Beijing Renxing, features industrial-grade capabilities and a smart computing platform, achieving millimeter-level dynamic operation precision [3] - The "HuiSiKaiWu" platform, launched in March 2025, is the world's first general-purpose embodied intelligence platform, integrating AI-driven task planning and data-driven skill execution [4] Group 3: Applications and Use Cases - The "XiaoNuo" robot, developed by Songyan Power, can perform over 200 micro-expressions and is designed for various applications, including education, commercial guidance, and psychological therapy [6] - The AI catheter shaping robot developed by Qianglian Zhichuang can automatically shape catheters for brain surgery, significantly reducing operation time and improving success rates [7] - Robots are being applied in diverse fields such as industrial manufacturing, commercial services, education, medical care, agriculture, and landscaping, with 199 innovative products implemented in 134 application scenarios since 2023 [9] Group 4: Investment and Support - Beijing's government has established a 10 billion yuan robot industry development fund, supported by prominent investment firms, creating a comprehensive investment framework from early-stage R&D to application [10] - The city has a robust public service system, including the National Robot Inspection and Testing Public Service Platform and the World Robot Conference, which has been held successfully for ten years [10]

Group 1 - The article highlights the global debut of the AI catheter shaping robot at the OCIN2025 conference, showcasing advancements in intelligent diagnosis and treatment for cerebrovascular diseases [3][6] - The AI catheter shaping robot, developed in collaboration with leading medical teams, has received China's first "AI + treatment" Class III medical device registration certificate [5] - The robot's live surgery demonstration allowed experts to observe its ability to automatically shape catheters and navigate complex vascular paths, emphasizing the innovation in cerebrovascular intervention surgery [6] Group 2 - Lingyi Biotech presented significant clinical progress on gene therapy drugs for Wilson's disease and Gaucher disease type I at the ASGCT2025 conference, indicating important scientific and clinical implications [8] - Huayi Lekan introduced a novel gene therapy candidate for phenylketonuria (PKU) at ASGCT2025, which utilizes an innovative mechanism to silence mutated PAH genes and restore normal function [11][12] - New gene editing therapy GEN6050X for Duchenne muscular dystrophy (DMD) showed promising biomarker data, suggesting its potential to enhance cardiac function and overall patient outcomes [14] Group 3 - Xibiman Biotech announced early clinical results for C-CAR168, a novel CAR-T therapy targeting refractory lupus nephritis, indicating significant progress in treating autoimmune diseases [15] - The NyokAssist® artificial heart device demonstrated encouraging preliminary results at the ISHLT2025 conference, showcasing its design and low complication rates [18] - Shizai Biotech received approval for clinical trials of a new drug for amyotrophic lateral sclerosis (ALS), marking a significant step in addressing one of the "five major incurable diseases" [20] Group 4 - The establishment of a key laboratory for recombinant protein synthesis in Beijing, co-founded by Yuanwei Technology and Tsinghua University, aims to tackle challenges in the industrial application of synthetic biology [22][24] - Haowei Medical completed the first patient enrollment for a clinical trial of absorbable embolization microspheres for symptomatic uterine fibroids, marking a milestone in interventional treatment in China [26] - Sequoia China has invested in over 200 high-growth medical health companies, with more than 45 successfully completing IPOs across various stock markets [27][28]

5月11日，第二十七届中国北京国际科技产业博览会（简称"北京科博会"）成功闭幕。以"科技引领创享未来"为主题，本届科博会设有信息科技、智能制 造、医药健康、绿色双碳、数字经济和区域创新6个专题展区，吸引了800余家中外企业和机构参展。 在本届北京科博会上，多项创新成果展出。其中，AI技术与医疗健康的深度融合成为亮点，智能手术机器人正助力提升基层医疗水平，更精准、稳定的疼 痛管理得以实现。我国医疗产业自主可控进展显著，部分企业实现全产业链国产化，另一些则在关键技术上突破国外垄断。"中国智造"不仅在国内大放异 彩，更在国际舞台上展现出强大的竞争力。 AI融入医疗健康：手术机器人加持基层医疗 疼痛管理更精准 北京科博会期间，多款融合了AI技术的创新医疗器械惊艳亮相。 亦庄展区内，强联智创(北京)科技有限公司的展位上，手术模拟器展示了在神经介入手术中，使用AI导管塑形机器人进行塑形后的微导管在脑血管模型中进 行模拟手术操作的过程。 北京科博会上，强联智创展出的导管塑形机器人。 强联智创董事长助理曾烨对贝壳财经记者介绍，神经介入手术在外科手术中难度极大，建立通路需对耗材进行预塑形，以往全靠医生凭经验想象完成，现在 手术 ...

金仕生物 全球首款预装干瓣Prostyle A® 获批上市 4月9日，金仕生物宣布由公司自主研发的 Prostyle A®经导管人工主动脉瓣膜置换系统-干法预装可回收输送 系统 获得国家药品监督管理局 （NMPA） 批准上市 （ 国械注准20253130729） 。 作为全球首款预装干瓣，金仕生物推出的新一代介入主动脉瓣Prostyle A®集成了众多瓣膜领域的前沿技 术，拥有干瓣技术、巧妙便捷的预装系统、卓越的瓣膜血流动力学性能和耐久性，优秀的输送性和通过 性，平稳的释放和可靠的锚定等特点。金仕生物自主创新的干瓣技术，在国内、欧洲、美国、日本等国家 享有专利保护。这一产品的出现，迎来中国TAVR的新时代 ——干瓣时代。 艾柯医疗 全新血流导向密网支架系统"Lattice COUPLE"成功获批 近日，艾柯医疗全新血流导向密网支架系统"Lattice COUPLE"，成功获得国家药监局批准注册 （ 注册证编 号：国械注准20253130668） 。至此， 艾柯医疗成为神经介入行业首家拥有三张密网注册证的企业 。 微光医疗 FDA 首次批准中国高端腔内介入影像设备 4月11日，微光医疗宣布其两款冠脉OCT设备及 ...